igf-1 lr3 risks hypoglycemia organ growth 40 YEARS OF IGF1: Insulin-like factors: actions on the skeleton in: Journal of Molecular Endocrinology Volume 61 Issue 1 (2018) IGF-1 LR3 Before and After:
Description
Exp Biol Med (Maywood) 228(8):891897 Koshinaka K, Toshinai K, Mohammad A, Noma K, Oshikawa M, Ueno H, Yamaguchi H, Nakazato M (2011) Therapeutic potential of ghrelin treatment for unloading-induced muscle atrophy in mice
E.ThomasG.HamurcuM.GezginS.et al
Data are shown as means standard deviation
Not all ER-positive BC patients are responsive to endocrine therapy ( de novo resistance)
FoxO1-deficient -cells lose their identity and revert to pancreatic endocrine progenitors characterized by expressing high levels of neurogenin-3 (Neurog3 high ), and no insulin and MafA expression 22
